Market Overview

Benzinga's Top Downgrades

Related THOR
Benzinga's Top Upgrades
UPDATE: Credit Suisse Upgrades Thoratec On Higher Near-Term Cost Assumptions
Related LOW
3 Retail Stocks To Add To Your Black Friday Shopping List
Benzinga's Top #PreMarket Gainers
Making Money With Charles Payne: 11/19/14 (Fox Business)

Analysts at Goldman Sachs downgraded Thoratec (NASDAQ: THOR) from “buy” to “neutral.” The target price for Thoratec has been lowered from $42 to $37. Thoratec's shares closed at $32.60 on Friday.

Analysts at Oppenheimer downgraded Lowe's Companies (NYSE: LOW) from “outperform” to “perform.” The target price for Lowe's is set to $46. Lowe's shares closed at $42.67 on Friday.

Analysts at Keefe Bruyette & Woods downgraded Bank of America (NYSE: BAC) from “outperform” to “perform.” Bank of America's shares closed at $13.43 on Friday.

Jefferies downgraded Bed Bath & Beyond (NASDAQ: BBBY) from “buy” to “hold.” The target price for Bed Bath & Beyond has been lowered from $76 to $71. Bed Bath & Beyond's shares closed at $69.11 on Friday.

Latest Ratings for THOR

DateFirmActionFromTo
Nov 2014Credit SuisseUpgradesNeutralOutperform
Nov 2014Wells FargoUpgradesMarket PerformOutperform
Nov 2014Bank of AmericaMaintainsNeutral

View More Analyst Ratings for THOR
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (BBBY + BAC)

Around the Web, We're Loving...

Get Benzinga's Newsletters